Cargando…
Hemoperfusion and intravenous immunoglobulins for refractory gastrointestinal involvement in pediatric Henoch-Schönlein purpura: a single-center retrospective cohort study
BACKGROUND: Henoch-Schönlein purpura (HSP) with refractory gastrointestinal (GI) symptoms is always difficult to handle because of its resistance to supportive therapies and glucocorticoid. This study aimed to evaluate the efficacy of hemoperfusion (HP) and intravenous immunoglobulins (IVIG) therapi...
Autores principales: | Zhang, Xiaolu, Che, Ruochen, Xu, Haisheng, Ding, Guixia, Zhao, Fei, Huang, Songming, Zhang, Aihua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716741/ https://www.ncbi.nlm.nih.gov/pubmed/36460986 http://dx.doi.org/10.1186/s12887-022-03709-0 |
Ejemplares similares
-
Changes of inflammatory mediators and oxidative stress indicators in children with Henoch-Schönlein purpura and clinical effects of hemoperfusion in the treatment of severe Henoch-Schönlein purpura with gastrointestinal involvement in children
por: Zhu, Ying, et al.
Publicado: (2019) -
Gastrointestinal manifestations of Henoch-Schönlein purpura.
por: Park, S. H., et al.
Publicado: (1990) -
Intravenous Cyclophosphamide Therapy in Adults with Henoch-Schönlein Purpura
por: Shin, Jae Il, et al.
Publicado: (2008) -
Gut Microbiota Variations between Henoch-Schonlein Purpura and Henoch-Schonlein Purpura Nephritis
por: Zhou, Fang, et al.
Publicado: (2022) -
Henoch–Schonlein purpura in mesothelioma
por: Joshi, Stuti, et al.
Publicado: (2014)